Long-Term Follow-Up of Malignancy Biomarkers in Patients With Barrett's Esophagus Undergoing Medical or Surgical Treatment

Objective:This study aims to compare some validated biomarkers of malignancy (Ki-67, p53, and apoptosis) between 2 groups of patients with Barrett's esophagus (BE) undergoing randomly medical or surgical treatment.Background:The treatment of choice to prevent the malignant progression of BE remains